Floris Dammeijer

The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes

Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder et al. · Cancer Cell · 2020 · 626 citations · Full text

Cancer Immunosurveillance, Immunology, Tumor Immunity +7

Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy

Floris Dammeijer, Lysanne A. Lievense, Margaretha E. Kaijen-Lambers et al. · Cancer Immunology Research · 2017 · 137 citations · Full text

PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance

Mandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters et al. · Science Immunology · 2023 · 93 citations · Full text

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

Sai Ping Lau, Nadine van Montfoort, Priscilla Kinderman et al. · Journal for ImmunoTherapy of Cancer · 2020 · 60 citations · Full text

Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial

Cornedine J. de Gooijer, Vincent van der Noort, Jos A. Stigt et al. · The Lancet Respiratory Medicine · 2021 · 47 citations · Full text

First-line Chemotherapy, Switch-maintenance Gemcitabine, Malignant Disease +8